India’s Cipla ties up with Serum Institute to sell vaccines in South Africa
Cipla Ltd, India's fourth-largest drugmaker by sales, said on Thursday it had agreed to an exclusive deal with Serum Institute of India to supply vaccines to South Africa, adding a new market to their partnership in India and Europe. Cipla&039;s unit Cipla Medpro, South Africa&039;s third-largest drugs manufacturer, will be responsible for obtaining regulatory approvals and marketing of the vaccines under the deal terms, Cipla said in a statement to exchanges.
